Invention Grant
- Patent Title: Substituted pyridines that are JNK inhibitors
- Patent Title (中): 取代的吡啶是JNK抑制剂
-
Application No.: US12519731Application Date: 2007-12-17
-
Publication No.: US08278337B2Publication Date: 2012-10-02
- Inventor: David B. Belanger , M. Arshad Siddiqui , Patrick J. Curran , Blake Hamann , Lianyun Zhao , Panduranga Adulla P. Reddy , Praveen K. Tadikonda , Gerald W. Shipps, Jr. , Umar Faruk Mansoor
- Applicant: David B. Belanger , M. Arshad Siddiqui , Patrick J. Curran , Blake Hamann , Lianyun Zhao , Panduranga Adulla P. Reddy , Praveen K. Tadikonda , Gerald W. Shipps, Jr. , Umar Faruk Mansoor
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme
- Current Assignee: Merck Sharp & Dohme
- Current Assignee Address: US NJ Rahway
- Agent Henry C. Jeanette; David A. Muthard
- International Application: PCT/US2007/025764 WO 20071217
- International Announcement: WO2008/082487 WO 20080710
- Main IPC: A61K31/44
- IPC: A61K31/44
Abstract:
Disclosed are compounds of the formula (I) wherein X is N or CH, and Y is N or CR5. Also disclosed are methods of treating JNK and ERK mediated diseases using the compounds of formula 1.0.
Public/Granted literature
- US20100179141A1 NOVEL JNK INHIBITORS Public/Granted day:2010-07-15
Information query
